Radiofrequency Ablation for Liver Metastases after Transarterial Chemoembolization: A Systemic Analysis

• DOI: 10.7314/apjcp.2015.16.12.5101
• Publication Date: 2015-09-10T14:37:29Z
• Authors: Chuan Xu; Peng-Hua Lv; Xin-En Huang; Shu-Xiang Wang; Ling Sun; Fu-An Wang
• Keywords: Clinical Trials as Topic; Liver Neoplasms; Prognosis; 3. Good health; Survival Rate; 03 medical and health sciences; 0302 clinical medicine; Meta-Analysis as Topic; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Humans; Chemoembolization, Therapeutic; Neoplasm Recurrence, Local; Neoplasm Staging

This systemic analysis was conducted to evaluate tumor recurrence rate and one-year survival for patients with liver metastases received radiofrequency ablation after transarterial chemoembolization introduce a new method of by puncture navigation technology single chemoembolization.Clinical studies evaluating rate. Appling the innova trackvision software process one using treat metastases.3 clinical which including 235 transaeterial were considered eligible inclusion. Systemic suggested that 23% (54/235), 76% (178/235). The procedure performed successfully patient good prognosis.This suggests is could receive relatively prognosis.